Pfizer’s support of the Global Goals is rooted in our belief that every individual deserves to live a longer, healthier, more productive life.
Aspen Healthcare was established in March 1998 following a management buyout of Paracelsus UK from Paracelsus Kliniken Deutschland GmbH (an independent healthcare provider founded in 1987). At the time of the buyout, the company consisted of two acute care community hospitals: Parkside Hospital in Wimbledon, SW London and Holly House Hospital (now known at The Holly Private Hospital) in Buckhurst Hill, Essex. United Surgical Partners International (USPI), backed by Welsh Carson Anderson and Stowe (WCAS), acquired Aspen in April 2000. Our mission is to provide first-class independent healthcare for the local community in a safe, comfortable and welcoming environment; one in which we would be happy to treat our own families. Beyond Compliance Going above and beyond to improve our business Being recognised for outstanding Being better than the rest Committed to going the extra mile; doing more than just enough Articulating your point of view; speak up when you believe it’s right or wrong Aspire to be the best in all we do and giving my very best
Medtronic is looking at how our technology and expertise can be used in new and exciting ways, but we also realize it’s the partnerships we form around the world that can lead to the biggest advances for patients, hospitals, and systems.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, we transform scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life
Providing creative healthcare solution and quality services for our customers
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.